NYLIM
RUBY

New York Life Investment Management’s Rubius Therapeutics, Inc RUBY Stock Holding History

New York Life Investment Management’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-102,251
Closed -$17.6K – 1447
2022
Q4 		$17.6K Buy
102,251
+10,908
+12% +$2.98K ﹤0.01% 1195
2022
Q3 		$40K Buy
91,343
+6,708
+8% +$5.03K ﹤0.01% 1202
2022
Q2 		$72K Buy
+84,635
New +$142K ﹤0.01% 1246

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

New York Life Investment Management's RUBY Position: Q1 2023 in Review

New York Life Investment Management sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 102,251 shares — an estimated $17.6K sold.

New York Life Investment Management first reported a position in RUBY in Q2 2022 and held it in 3 quarters. The position peaked at $72K in Q2 2022. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • New York Life Investment Management reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • New York Life Investment Management sold 102,251 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $17.6K.
  • New York Life Investment Management first reported a position in Rubius Therapeutics, Inc in Q2 2022 and held it in 3 quarters.
  • New York Life Investment Management's Rubius Therapeutics, Inc position peaked at $72K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on New York Life Investment Management's 13F filing for Q1 2023, filed 8 May 2023.